nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLCO1B1—Sulfasalazine—Crohn's disease	0.186	0.554	CbGbCtD
Sirolimus—CYP3A5—Sulfasalazine—Crohn's disease	0.0819	0.244	CbGbCtD
Sirolimus—ABCB1—Prednisone—Crohn's disease	0.0426	0.127	CbGbCtD
Sirolimus—CYP3A4—Prednisone—Crohn's disease	0.0255	0.076	CbGbCtD
Sirolimus—EIF4E—lymphoid tissue—Crohn's disease	0.00718	0.0907	CbGeAlD
Sirolimus—EIF4E—digestive system—Crohn's disease	0.00709	0.0896	CbGeAlD
Sirolimus—FGF2—smooth muscle tissue—Crohn's disease	0.00548	0.0692	CbGeAlD
Sirolimus—FGF2—mammalian vulva—Crohn's disease	0.00493	0.0623	CbGeAlD
Sirolimus—MTOR—epithelium—Crohn's disease	0.00361	0.0456	CbGeAlD
Sirolimus—MTOR—smooth muscle tissue—Crohn's disease	0.00348	0.0439	CbGeAlD
Sirolimus—MTOR—skin of body—Crohn's disease	0.00343	0.0433	CbGeAlD
Sirolimus—FKBP1A—epithelium—Crohn's disease	0.00324	0.041	CbGeAlD
Sirolimus—MTOR—mammalian vulva—Crohn's disease	0.00313	0.0395	CbGeAlD
Sirolimus—FKBP1A—smooth muscle tissue—Crohn's disease	0.00313	0.0395	CbGeAlD
Sirolimus—FKBP1A—skin of body—Crohn's disease	0.00309	0.039	CbGeAlD
Sirolimus—FKBP1A—mammalian vulva—Crohn's disease	0.00281	0.0356	CbGeAlD
Sirolimus—MTOR—lymphoid tissue—Crohn's disease	0.00278	0.0351	CbGeAlD
Sirolimus—MTOR—digestive system—Crohn's disease	0.00274	0.0347	CbGeAlD
Sirolimus—FKBP1A—lymphoid tissue—Crohn's disease	0.0025	0.0316	CbGeAlD
Sirolimus—FGF2—lymph node—Crohn's disease	0.00247	0.0312	CbGeAlD
Sirolimus—FKBP1A—digestive system—Crohn's disease	0.00247	0.0312	CbGeAlD
Sirolimus—SLC47A1—mammalian vulva—Crohn's disease	0.00242	0.0306	CbGeAlD
Sirolimus—SLC47A1—digestive system—Crohn's disease	0.00212	0.0268	CbGeAlD
Sirolimus—SLCO1B1—digestive system—Crohn's disease	0.00209	0.0265	CbGeAlD
Sirolimus—MTOR—lymph node—Crohn's disease	0.00157	0.0198	CbGeAlD
Sirolimus—FKBP1A—lymph node—Crohn's disease	0.00141	0.0178	CbGeAlD
Sirolimus—SLC47A1—lymph node—Crohn's disease	0.00121	0.0153	CbGeAlD
Sirolimus—CYP3A5—digestive system—Crohn's disease	0.00107	0.0136	CbGeAlD
Sirolimus—Increased appetite—Mesalazine—Crohn's disease	0.000961	0.00264	CcSEcCtD
Sirolimus—Atrial fibrillation—Mesalazine—Crohn's disease	0.000953	0.00261	CcSEcCtD
Sirolimus—Renal impairment—Mesalazine—Crohn's disease	0.000949	0.0026	CcSEcCtD
Sirolimus—Anaemia—Mercaptopurine—Crohn's disease	0.000926	0.00254	CcSEcCtD
Sirolimus—Osteoarthritis—Mesalazine—Crohn's disease	0.000903	0.00248	CcSEcCtD
Sirolimus—Leukopenia—Mercaptopurine—Crohn's disease	0.000897	0.00246	CcSEcCtD
Sirolimus—Affect lability—Mesalazine—Crohn's disease	0.000889	0.00244	CcSEcCtD
Sirolimus—Face oedema—Mesalazine—Crohn's disease	0.000872	0.00239	CcSEcCtD
Sirolimus—Mood swings—Mesalazine—Crohn's disease	0.000856	0.00235	CcSEcCtD
Sirolimus—Arthralgia—Mercaptopurine—Crohn's disease	0.000853	0.00234	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000847	0.00232	CcSEcCtD
Sirolimus—Blood creatinine increased—Mesalazine—Crohn's disease	0.000846	0.00232	CcSEcCtD
Sirolimus—Pancreatitis—Azathioprine—Crohn's disease	0.00084	0.0023	CcSEcCtD
Sirolimus—Liver function test abnormal—Mesalazine—Crohn's disease	0.000834	0.00229	CcSEcCtD
Sirolimus—Abscess—Prednisone—Crohn's disease	0.000832	0.00228	CcSEcCtD
Sirolimus—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000825	0.00226	CcSEcCtD
Sirolimus—Oedema—Mercaptopurine—Crohn's disease	0.000818	0.00224	CcSEcCtD
Sirolimus—Breast disorder—Mesalazine—Crohn's disease	0.000816	0.00224	CcSEcCtD
Sirolimus—Pancytopenia—Azathioprine—Crohn's disease	0.000814	0.00223	CcSEcCtD
Sirolimus—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000813	0.00223	CcSEcCtD
Sirolimus—Glycosuria—Prednisone—Crohn's disease	0.000813	0.00223	CcSEcCtD
Sirolimus—CYP3A4—digestive system—Crohn's disease	0.000807	0.0102	CbGeAlD
Sirolimus—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000801	0.0022	CcSEcCtD
Sirolimus—Gastritis—Mesalazine—Crohn's disease	0.000799	0.00219	CcSEcCtD
Sirolimus—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000797	0.00218	CcSEcCtD
Sirolimus—Skin disorder—Mercaptopurine—Crohn's disease	0.000794	0.00218	CcSEcCtD
Sirolimus—Abdominal distension—Mesalazine—Crohn's disease	0.000786	0.00216	CcSEcCtD
Sirolimus—Acne—Prednisone—Crohn's disease	0.000782	0.00215	CcSEcCtD
Sirolimus—Asthma—Mesalazine—Crohn's disease	0.000781	0.00214	CcSEcCtD
Sirolimus—Dysphagia—Mesalazine—Crohn's disease	0.000781	0.00214	CcSEcCtD
Sirolimus—Influenza—Mesalazine—Crohn's disease	0.000781	0.00214	CcSEcCtD
Sirolimus—Anorexia—Mercaptopurine—Crohn's disease	0.00078	0.00214	CcSEcCtD
Sirolimus—Pneumonia—Azathioprine—Crohn's disease	0.000769	0.00211	CcSEcCtD
Sirolimus—Pancreatitis—Mesalazine—Crohn's disease	0.000765	0.0021	CcSEcCtD
Sirolimus—Infestation—Azathioprine—Crohn's disease	0.000764	0.0021	CcSEcCtD
Sirolimus—Infestation NOS—Azathioprine—Crohn's disease	0.000764	0.0021	CcSEcCtD
Sirolimus—Bronchitis—Mesalazine—Crohn's disease	0.000751	0.00206	CcSEcCtD
Sirolimus—ABCB1—epithelium—Crohn's disease	0.000751	0.00948	CbGeAlD
Sirolimus—Amenorrhoea—Prednisone—Crohn's disease	0.000749	0.00205	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000745	0.00204	CcSEcCtD
Sirolimus—Pancytopenia—Mesalazine—Crohn's disease	0.000741	0.00203	CcSEcCtD
Sirolimus—Dysuria—Mesalazine—Crohn's disease	0.00073	0.002	CcSEcCtD
Sirolimus—Neutropenia—Mesalazine—Crohn's disease	0.00073	0.002	CcSEcCtD
Sirolimus—Viral infection—Prednisone—Crohn's disease	0.000729	0.002	CcSEcCtD
Sirolimus—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000725	0.00199	CcSEcCtD
Sirolimus—Arthropathy—Prednisone—Crohn's disease	0.000724	0.00199	CcSEcCtD
Sirolimus—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000723	0.00198	CcSEcCtD
Sirolimus—Pollakiuria—Mesalazine—Crohn's disease	0.000721	0.00198	CcSEcCtD
Sirolimus—Decreased appetite—Mercaptopurine—Crohn's disease	0.000711	0.00195	CcSEcCtD
Sirolimus—Weight increased—Mesalazine—Crohn's disease	0.00071	0.00195	CcSEcCtD
Sirolimus—Weight decreased—Mesalazine—Crohn's disease	0.000706	0.00194	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000706	0.00194	CcSEcCtD
Sirolimus—Leukocytosis—Prednisone—Crohn's disease	0.0007	0.00192	CcSEcCtD
Sirolimus—Pneumonia—Mesalazine—Crohn's disease	0.0007	0.00192	CcSEcCtD
Sirolimus—Infestation NOS—Mesalazine—Crohn's disease	0.000696	0.00191	CcSEcCtD
Sirolimus—Infestation—Mesalazine—Crohn's disease	0.000696	0.00191	CcSEcCtD
Sirolimus—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000696	0.00191	CcSEcCtD
Sirolimus—Cataract—Prednisone—Crohn's disease	0.000692	0.0019	CcSEcCtD
Sirolimus—Haemoglobin—Azathioprine—Crohn's disease	0.000689	0.00189	CcSEcCtD
Sirolimus—Haemorrhage—Azathioprine—Crohn's disease	0.000686	0.00188	CcSEcCtD
Sirolimus—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000682	0.00187	CcSEcCtD
Sirolimus—Stomatitis—Mesalazine—Crohn's disease	0.000678	0.00186	CcSEcCtD
Sirolimus—Urinary tract infection—Mesalazine—Crohn's disease	0.000677	0.00186	CcSEcCtD
Sirolimus—Conjunctivitis—Mesalazine—Crohn's disease	0.000677	0.00186	CcSEcCtD
Sirolimus—Sweating—Mesalazine—Crohn's disease	0.000667	0.00183	CcSEcCtD
Sirolimus—Haematuria—Mesalazine—Crohn's disease	0.000664	0.00182	CcSEcCtD
Sirolimus—Hiccups—Prednisone—Crohn's disease	0.000658	0.00181	CcSEcCtD
Sirolimus—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000658	0.00181	CcSEcCtD
Sirolimus—Epistaxis—Mesalazine—Crohn's disease	0.000656	0.0018	CcSEcCtD
Sirolimus—Sinusitis—Mesalazine—Crohn's disease	0.000653	0.00179	CcSEcCtD
Sirolimus—ABCB1—mammalian vulva—Crohn's disease	0.000651	0.00822	CbGeAlD
Sirolimus—Body temperature increased—Mercaptopurine—Crohn's disease	0.000647	0.00177	CcSEcCtD
Sirolimus—Haemoglobin—Mesalazine—Crohn's disease	0.000628	0.00172	CcSEcCtD
Sirolimus—Rhinitis—Mesalazine—Crohn's disease	0.000626	0.00172	CcSEcCtD
Sirolimus—Fluid retention—Prednisone—Crohn's disease	0.000625	0.00171	CcSEcCtD
Sirolimus—Haemorrhage—Mesalazine—Crohn's disease	0.000625	0.00171	CcSEcCtD
Sirolimus—Pharyngitis—Mesalazine—Crohn's disease	0.00062	0.0017	CcSEcCtD
Sirolimus—Immune system disorder—Azathioprine—Crohn's disease	0.00062	0.0017	CcSEcCtD
Sirolimus—Mediastinal disorder—Azathioprine—Crohn's disease	0.000618	0.0017	CcSEcCtD
Sirolimus—Neuropathy—Prednisone—Crohn's disease	0.000618	0.00169	CcSEcCtD
Sirolimus—Urinary tract disorder—Mesalazine—Crohn's disease	0.000617	0.00169	CcSEcCtD
Sirolimus—Oedema peripheral—Mesalazine—Crohn's disease	0.000615	0.00169	CcSEcCtD
Sirolimus—Chills—Azathioprine—Crohn's disease	0.000615	0.00169	CcSEcCtD
Sirolimus—Connective tissue disorder—Mesalazine—Crohn's disease	0.000614	0.00168	CcSEcCtD
Sirolimus—Urethral disorder—Mesalazine—Crohn's disease	0.000612	0.00168	CcSEcCtD
Sirolimus—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000603	0.00165	CcSEcCtD
Sirolimus—Oesophagitis—Prednisone—Crohn's disease	0.000601	0.00165	CcSEcCtD
Sirolimus—Ecchymosis—Prednisone—Crohn's disease	0.000595	0.00163	CcSEcCtD
Sirolimus—Pulmonary oedema—Prednisone—Crohn's disease	0.000586	0.00161	CcSEcCtD
Sirolimus—Tinnitus—Mesalazine—Crohn's disease	0.000583	0.0016	CcSEcCtD
Sirolimus—Cardiac disorder—Mesalazine—Crohn's disease	0.00058	0.00159	CcSEcCtD
Sirolimus—ABCB1—lymphoid tissue—Crohn's disease	0.000578	0.0073	CbGeAlD
Sirolimus—Sepsis—Prednisone—Crohn's disease	0.000571	0.00157	CcSEcCtD
Sirolimus—ABCB1—digestive system—Crohn's disease	0.000571	0.00721	CbGeAlD
Sirolimus—Angiopathy—Mesalazine—Crohn's disease	0.000567	0.00155	CcSEcCtD
Sirolimus—Immune system disorder—Mesalazine—Crohn's disease	0.000564	0.00155	CcSEcCtD
Sirolimus—Mediastinal disorder—Mesalazine—Crohn's disease	0.000563	0.00154	CcSEcCtD
Sirolimus—Chills—Mesalazine—Crohn's disease	0.000561	0.00154	CcSEcCtD
Sirolimus—Diarrhoea—Mercaptopurine—Crohn's disease	0.00056	0.00153	CcSEcCtD
Sirolimus—Ill-defined disorder—Azathioprine—Crohn's disease	0.000554	0.00152	CcSEcCtD
Sirolimus—Thrombophlebitis—Prednisone—Crohn's disease	0.000552	0.00151	CcSEcCtD
Sirolimus—Anaemia—Azathioprine—Crohn's disease	0.000552	0.00151	CcSEcCtD
Sirolimus—Diabetes mellitus—Prednisone—Crohn's disease	0.000549	0.00151	CcSEcCtD
Sirolimus—Malaise—Azathioprine—Crohn's disease	0.000538	0.00148	CcSEcCtD
Sirolimus—Flatulence—Mesalazine—Crohn's disease	0.000536	0.00147	CcSEcCtD
Sirolimus—Leukopenia—Azathioprine—Crohn's disease	0.000534	0.00147	CcSEcCtD
Sirolimus—Tension—Mesalazine—Crohn's disease	0.000534	0.00146	CcSEcCtD
Sirolimus—Nervousness—Mesalazine—Crohn's disease	0.000528	0.00145	CcSEcCtD
Sirolimus—Cardiac failure congestive—Prednisone—Crohn's disease	0.000527	0.00145	CcSEcCtD
Sirolimus—Back pain—Mesalazine—Crohn's disease	0.000526	0.00144	CcSEcCtD
Sirolimus—Muscle spasms—Mesalazine—Crohn's disease	0.000523	0.00143	CcSEcCtD
Sirolimus—Vomiting—Mercaptopurine—Crohn's disease	0.00052	0.00143	CcSEcCtD
Sirolimus—Injury—Prednisone—Crohn's disease	0.00052	0.00143	CcSEcCtD
Sirolimus—Rash—Mercaptopurine—Crohn's disease	0.000516	0.00141	CcSEcCtD
Sirolimus—Dermatitis—Mercaptopurine—Crohn's disease	0.000515	0.00141	CcSEcCtD
Sirolimus—Tremor—Mesalazine—Crohn's disease	0.00051	0.0014	CcSEcCtD
Sirolimus—Increased appetite—Prednisone—Crohn's disease	0.000509	0.00139	CcSEcCtD
Sirolimus—Myalgia—Azathioprine—Crohn's disease	0.000508	0.00139	CcSEcCtD
Sirolimus—Arthralgia—Azathioprine—Crohn's disease	0.000508	0.00139	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000505	0.00138	CcSEcCtD
Sirolimus—Ill-defined disorder—Mesalazine—Crohn's disease	0.000505	0.00138	CcSEcCtD
Sirolimus—Anaemia—Mesalazine—Crohn's disease	0.000503	0.00138	CcSEcCtD
Sirolimus—Discomfort—Azathioprine—Crohn's disease	0.000502	0.00138	CcSEcCtD
Sirolimus—Angioedema—Mesalazine—Crohn's disease	0.000497	0.00136	CcSEcCtD
Sirolimus—Malaise—Mesalazine—Crohn's disease	0.00049	0.00135	CcSEcCtD
Sirolimus—Syncope—Mesalazine—Crohn's disease	0.000488	0.00134	CcSEcCtD
Sirolimus—Leukopenia—Mesalazine—Crohn's disease	0.000487	0.00134	CcSEcCtD
Sirolimus—Nausea—Mercaptopurine—Crohn's disease	0.000486	0.00133	CcSEcCtD
Sirolimus—Infection—Azathioprine—Crohn's disease	0.000484	0.00133	CcSEcCtD
Sirolimus—Palpitations—Mesalazine—Crohn's disease	0.000481	0.00132	CcSEcCtD
Sirolimus—Loss of consciousness—Mesalazine—Crohn's disease	0.000478	0.00131	CcSEcCtD
Sirolimus—Osteoarthritis—Prednisone—Crohn's disease	0.000478	0.00131	CcSEcCtD
Sirolimus—Thrombocytopenia—Azathioprine—Crohn's disease	0.000477	0.00131	CcSEcCtD
Sirolimus—Cough—Mesalazine—Crohn's disease	0.000475	0.0013	CcSEcCtD
Sirolimus—Skin disorder—Azathioprine—Crohn's disease	0.000473	0.0013	CcSEcCtD
Sirolimus—Affect lability—Prednisone—Crohn's disease	0.00047	0.00129	CcSEcCtD
Sirolimus—Hypertension—Mesalazine—Crohn's disease	0.00047	0.00129	CcSEcCtD
Sirolimus—Myalgia—Mesalazine—Crohn's disease	0.000463	0.00127	CcSEcCtD
Sirolimus—Arthralgia—Mesalazine—Crohn's disease	0.000463	0.00127	CcSEcCtD
Sirolimus—Chest pain—Mesalazine—Crohn's disease	0.000463	0.00127	CcSEcCtD
Sirolimus—Anxiety—Mesalazine—Crohn's disease	0.000461	0.00127	CcSEcCtD
Sirolimus—Face oedema—Prednisone—Crohn's disease	0.000461	0.00127	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00046	0.00126	CcSEcCtD
Sirolimus—Discomfort—Mesalazine—Crohn's disease	0.000457	0.00125	CcSEcCtD
Sirolimus—Hypotension—Azathioprine—Crohn's disease	0.000455	0.00125	CcSEcCtD
Sirolimus—Mood swings—Prednisone—Crohn's disease	0.000453	0.00124	CcSEcCtD
Sirolimus—Confusional state—Mesalazine—Crohn's disease	0.000448	0.00123	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000444	0.00122	CcSEcCtD
Sirolimus—Oedema—Mesalazine—Crohn's disease	0.000444	0.00122	CcSEcCtD
Sirolimus—Anaphylactic shock—Mesalazine—Crohn's disease	0.000444	0.00122	CcSEcCtD
Sirolimus—Infection—Mesalazine—Crohn's disease	0.000441	0.00121	CcSEcCtD
Sirolimus—Shock—Mesalazine—Crohn's disease	0.000437	0.0012	CcSEcCtD
Sirolimus—Nervous system disorder—Mesalazine—Crohn's disease	0.000435	0.00119	CcSEcCtD
Sirolimus—Hypokalaemia—Prednisone—Crohn's disease	0.000435	0.00119	CcSEcCtD
Sirolimus—Thrombocytopenia—Mesalazine—Crohn's disease	0.000435	0.00119	CcSEcCtD
Sirolimus—Tachycardia—Mesalazine—Crohn's disease	0.000433	0.00119	CcSEcCtD
Sirolimus—Skin disorder—Mesalazine—Crohn's disease	0.000431	0.00118	CcSEcCtD
Sirolimus—Hyperhidrosis—Mesalazine—Crohn's disease	0.000429	0.00118	CcSEcCtD
Sirolimus—Anorexia—Mesalazine—Crohn's disease	0.000423	0.00116	CcSEcCtD
Sirolimus—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000421	0.00116	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000421	0.00115	CcSEcCtD
Sirolimus—Abdominal distension—Prednisone—Crohn's disease	0.000416	0.00114	CcSEcCtD
Sirolimus—Hypotension—Mesalazine—Crohn's disease	0.000415	0.00114	CcSEcCtD
Sirolimus—Pancreatitis—Prednisone—Crohn's disease	0.000405	0.00111	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000404	0.00111	CcSEcCtD
Sirolimus—Feeling abnormal—Azathioprine—Crohn's disease	0.000402	0.0011	CcSEcCtD
Sirolimus—Insomnia—Mesalazine—Crohn's disease	0.000401	0.0011	CcSEcCtD
Sirolimus—Paraesthesia—Mesalazine—Crohn's disease	0.000399	0.00109	CcSEcCtD
Sirolimus—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000398	0.00109	CcSEcCtD
Sirolimus—Dyspnoea—Mesalazine—Crohn's disease	0.000396	0.00109	CcSEcCtD
Sirolimus—Somnolence—Mesalazine—Crohn's disease	0.000395	0.00108	CcSEcCtD
Sirolimus—Dyspepsia—Mesalazine—Crohn's disease	0.000391	0.00107	CcSEcCtD
Sirolimus—Neutropenia—Prednisone—Crohn's disease	0.000386	0.00106	CcSEcCtD
Sirolimus—Decreased appetite—Mesalazine—Crohn's disease	0.000386	0.00106	CcSEcCtD
Sirolimus—Abdominal pain—Azathioprine—Crohn's disease	0.000385	0.00106	CcSEcCtD
Sirolimus—Body temperature increased—Azathioprine—Crohn's disease	0.000385	0.00106	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000383	0.00105	CcSEcCtD
Sirolimus—Erectile dysfunction—Prednisone—Crohn's disease	0.00038	0.00104	CcSEcCtD
Sirolimus—Constipation—Mesalazine—Crohn's disease	0.00038	0.00104	CcSEcCtD
Sirolimus—Pain—Mesalazine—Crohn's disease	0.00038	0.00104	CcSEcCtD
Sirolimus—Weight increased—Prednisone—Crohn's disease	0.000376	0.00103	CcSEcCtD
Sirolimus—Weight decreased—Prednisone—Crohn's disease	0.000374	0.00102	CcSEcCtD
Sirolimus—Hyperglycaemia—Prednisone—Crohn's disease	0.000373	0.00102	CcSEcCtD
Sirolimus—Feeling abnormal—Mesalazine—Crohn's disease	0.000366	0.001	CcSEcCtD
Sirolimus—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000363	0.000995	CcSEcCtD
Sirolimus—Neuropathy peripheral—Prednisone—Crohn's disease	0.000361	0.00099	CcSEcCtD
Sirolimus—Hypersensitivity—Azathioprine—Crohn's disease	0.000359	0.000985	CcSEcCtD
Sirolimus—Abdominal pain—Mesalazine—Crohn's disease	0.000351	0.000962	CcSEcCtD
Sirolimus—Body temperature increased—Mesalazine—Crohn's disease	0.000351	0.000962	CcSEcCtD
Sirolimus—Diarrhoea—Azathioprine—Crohn's disease	0.000333	0.000914	CcSEcCtD
Sirolimus—Haemoglobin—Prednisone—Crohn's disease	0.000332	0.000911	CcSEcCtD
Sirolimus—Haemorrhage—Prednisone—Crohn's disease	0.000331	0.000907	CcSEcCtD
Sirolimus—Hallucination—Prednisone—Crohn's disease	0.000329	0.000902	CcSEcCtD
Sirolimus—Hypersensitivity—Mesalazine—Crohn's disease	0.000327	0.000897	CcSEcCtD
Sirolimus—ABCB1—lymph node—Crohn's disease	0.000326	0.00412	CbGeAlD
Sirolimus—Connective tissue disorder—Prednisone—Crohn's disease	0.000325	0.000891	CcSEcCtD
Sirolimus—Dizziness—Azathioprine—Crohn's disease	0.000322	0.000884	CcSEcCtD
Sirolimus—Asthenia—Mesalazine—Crohn's disease	0.000318	0.000873	CcSEcCtD
Sirolimus—Pruritus—Mesalazine—Crohn's disease	0.000314	0.000861	CcSEcCtD
Sirolimus—Vomiting—Azathioprine—Crohn's disease	0.00031	0.00085	CcSEcCtD
Sirolimus—Rash—Azathioprine—Crohn's disease	0.000307	0.000843	CcSEcCtD
Sirolimus—Dermatitis—Azathioprine—Crohn's disease	0.000307	0.000842	CcSEcCtD
Sirolimus—Headache—Azathioprine—Crohn's disease	0.000305	0.000837	CcSEcCtD
Sirolimus—Diarrhoea—Mesalazine—Crohn's disease	0.000304	0.000833	CcSEcCtD
Sirolimus—Angiopathy—Prednisone—Crohn's disease	0.0003	0.000823	CcSEcCtD
Sirolimus—Immune system disorder—Prednisone—Crohn's disease	0.000299	0.000819	CcSEcCtD
Sirolimus—Dizziness—Mesalazine—Crohn's disease	0.000294	0.000805	CcSEcCtD
Sirolimus—Nausea—Azathioprine—Crohn's disease	0.000289	0.000794	CcSEcCtD
Sirolimus—Malnutrition—Prednisone—Crohn's disease	0.000288	0.000789	CcSEcCtD
Sirolimus—Vomiting—Mesalazine—Crohn's disease	0.000282	0.000774	CcSEcCtD
Sirolimus—Rash—Mesalazine—Crohn's disease	0.00028	0.000768	CcSEcCtD
Sirolimus—Dermatitis—Mesalazine—Crohn's disease	0.00028	0.000767	CcSEcCtD
Sirolimus—Headache—Mesalazine—Crohn's disease	0.000278	0.000763	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—Crohn's disease	0.000267	0.000732	CcSEcCtD
Sirolimus—Anaemia—Prednisone—Crohn's disease	0.000266	0.000729	CcSEcCtD
Sirolimus—Agitation—Prednisone—Crohn's disease	0.000264	0.000725	CcSEcCtD
Sirolimus—Nausea—Mesalazine—Crohn's disease	0.000264	0.000723	CcSEcCtD
Sirolimus—Angioedema—Prednisone—Crohn's disease	0.000263	0.000721	CcSEcCtD
Sirolimus—Malaise—Prednisone—Crohn's disease	0.000259	0.000712	CcSEcCtD
Sirolimus—Syncope—Prednisone—Crohn's disease	0.000258	0.000708	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—Crohn's disease	0.000253	0.000694	CcSEcCtD
Sirolimus—Hypertension—Prednisone—Crohn's disease	0.000248	0.000681	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—Crohn's disease	0.000245	0.000672	CcSEcCtD
Sirolimus—Myalgia—Prednisone—Crohn's disease	0.000245	0.000672	CcSEcCtD
Sirolimus—Anxiety—Prednisone—Crohn's disease	0.000244	0.00067	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000243	0.000667	CcSEcCtD
Sirolimus—Discomfort—Prednisone—Crohn's disease	0.000242	0.000664	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—Crohn's disease	0.000235	0.000644	CcSEcCtD
Sirolimus—Oedema—Prednisone—Crohn's disease	0.000235	0.000644	CcSEcCtD
Sirolimus—Infection—Prednisone—Crohn's disease	0.000233	0.00064	CcSEcCtD
Sirolimus—Shock—Prednisone—Crohn's disease	0.000231	0.000634	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—Crohn's disease	0.00023	0.000632	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—Crohn's disease	0.000229	0.000629	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—Crohn's disease	0.000228	0.000626	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—Crohn's disease	0.000227	0.000623	CcSEcCtD
Sirolimus—Anorexia—Prednisone—Crohn's disease	0.000224	0.000614	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000214	0.000587	CcSEcCtD
Sirolimus—Insomnia—Prednisone—Crohn's disease	0.000212	0.000583	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—Crohn's disease	0.000211	0.000578	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—Crohn's disease	0.000207	0.000567	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—Crohn's disease	0.000204	0.00056	CcSEcCtD
Sirolimus—Constipation—Prednisone—Crohn's disease	0.000201	0.000551	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—Crohn's disease	0.000194	0.000531	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—Crohn's disease	0.000192	0.000527	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—Crohn's disease	0.000186	0.000509	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—Crohn's disease	0.000186	0.000509	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—Crohn's disease	0.000173	0.000475	CcSEcCtD
Sirolimus—Asthenia—Prednisone—Crohn's disease	0.000169	0.000462	CcSEcCtD
Sirolimus—Pruritus—Prednisone—Crohn's disease	0.000166	0.000456	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—Crohn's disease	0.000161	0.000441	CcSEcCtD
Sirolimus—Dizziness—Prednisone—Crohn's disease	0.000155	0.000426	CcSEcCtD
Sirolimus—Vomiting—Prednisone—Crohn's disease	0.000149	0.00041	CcSEcCtD
Sirolimus—Rash—Prednisone—Crohn's disease	0.000148	0.000406	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—Crohn's disease	0.000148	0.000406	CcSEcCtD
Sirolimus—Headache—Prednisone—Crohn's disease	0.000147	0.000403	CcSEcCtD
Sirolimus—Nausea—Prednisone—Crohn's disease	0.000139	0.000383	CcSEcCtD
Sirolimus—EIF4E—Metabolism of proteins—CXCL8—Crohn's disease	0.000105	0.000476	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000104	0.000475	CbGpPWpGaD
Sirolimus—FGF2—Downstream signal transduction—IL6—Crohn's disease	0.000104	0.000472	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR—IL6—Crohn's disease	0.000103	0.00047	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—TLR4—Crohn's disease	0.000103	0.000468	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB2—IL6—Crohn's disease	0.000103	0.000468	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCR6—Crohn's disease	0.000103	0.000467	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CRP—Crohn's disease	0.000102	0.000466	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—IL6—Crohn's disease	0.000102	0.000465	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000102	0.000465	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—RASGRP1—Crohn's disease	0.000102	0.000462	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—IL6—Crohn's disease	0.000101	0.000459	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—SOCS1—Crohn's disease	0.000101	0.000458	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MTMR3—Crohn's disease	0.000101	0.000457	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RSPO3—Crohn's disease	0.000101	0.000457	CbGpPWpGaD
Sirolimus—FGF2—Disease—RBX1—Crohn's disease	0.000101	0.000457	CbGpPWpGaD
Sirolimus—FGF2—Disease—HSPA1B—Crohn's disease	0.000101	0.000457	CbGpPWpGaD
Sirolimus—MTOR—Signaling by Insulin receptor—IL6—Crohn's disease	0.0001	0.000456	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.0001	0.000455	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—STAT3—Crohn's disease	0.0001	0.000455	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—TYK2—Crohn's disease	9.96e-05	0.000453	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ICAM1—Crohn's disease	9.87e-05	0.000448	CbGpPWpGaD
Sirolimus—MTOR—Disease—GCKR—Crohn's disease	9.85e-05	0.000448	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NOD1—Crohn's disease	9.85e-05	0.000447	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—TLR4—Crohn's disease	9.83e-05	0.000446	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—SOCS1—Crohn's disease	9.69e-05	0.00044	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR in disease—IL6—Crohn's disease	9.64e-05	0.000438	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	9.64e-05	0.000438	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—IL6—Crohn's disease	9.64e-05	0.000438	CbGpPWpGaD
Sirolimus—FGF2—Immune System—UBE2D1—Crohn's disease	9.55e-05	0.000434	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—IL6—Crohn's disease	9.55e-05	0.000434	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SEL1L—Crohn's disease	9.54e-05	0.000433	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—JAK2—Crohn's disease	9.5e-05	0.000432	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.49e-05	0.000431	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—IL6—Crohn's disease	9.47e-05	0.00043	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—IL6—Crohn's disease	9.42e-05	0.000428	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—STAT3—Crohn's disease	9.4e-05	0.000427	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RBX1—Crohn's disease	9.29e-05	0.000422	CbGpPWpGaD
Sirolimus—FGF2—Immune System—RIPK2—Crohn's disease	9.26e-05	0.000421	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ITGA4—Crohn's disease	9.26e-05	0.000421	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CXCL8—Crohn's disease	9.25e-05	0.00042	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MTMR3—Crohn's disease	9.24e-05	0.00042	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SOCS1—Crohn's disease	9.21e-05	0.000418	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	9.07e-05	0.000412	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PTGER4—Crohn's disease	9.05e-05	0.000411	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ICAM1—Crohn's disease	9.05e-05	0.000411	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL3—Crohn's disease	9.03e-05	0.00041	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CCR6—Crohn's disease	8.94e-05	0.000406	CbGpPWpGaD
Sirolimus—FGF2—Disease—UBE2D1—Crohn's disease	8.82e-05	0.000401	CbGpPWpGaD
Sirolimus—FGF2—Immune System—RASGRP1—Crohn's disease	8.74e-05	0.000397	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR9—Crohn's disease	8.73e-05	0.000396	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD79A—Crohn's disease	8.71e-05	0.000396	CbGpPWpGaD
Sirolimus—MTOR—Disease—SLC11A1—Crohn's disease	8.71e-05	0.000396	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TYK2—Crohn's disease	8.67e-05	0.000394	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—IL6—Crohn's disease	8.58e-05	0.00039	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TAB1—Crohn's disease	8.55e-05	0.000388	CbGpPWpGaD
Sirolimus—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	8.53e-05	0.000388	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NOD2—Crohn's disease	8.4e-05	0.000382	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SMAD3—Crohn's disease	8.33e-05	0.000378	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—JAK2—Crohn's disease	8.27e-05	0.000376	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling of activated FGFR—IL6—Crohn's disease	8.21e-05	0.000373	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PTPN2—Crohn's disease	8.18e-05	0.000371	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—UBE2D1—Crohn's disease	8.15e-05	0.00037	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GPR65—Crohn's disease	8.11e-05	0.000369	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RBX1—Crohn's disease	8.09e-05	0.000367	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—IL6—Crohn's disease	8.08e-05	0.000367	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—TYK2—Crohn's disease	8.02e-05	0.000364	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SMAD3—Crohn's disease	7.95e-05	0.000361	CbGpPWpGaD
Sirolimus—FGF2—Immune System—SOCS1—Crohn's disease	7.92e-05	0.00036	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RIPK2—Crohn's disease	7.9e-05	0.000359	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	7.86e-05	0.000357	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—FADS1—Crohn's disease	7.84e-05	0.000356	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR6—Crohn's disease	7.79e-05	0.000354	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—IL6—Crohn's disease	7.71e-05	0.00035	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL3—Crohn's disease	7.71e-05	0.00035	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—IL6—Crohn's disease	7.68e-05	0.000349	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—TYK2—Crohn's disease	7.66e-05	0.000348	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—JAK2—Crohn's disease	7.65e-05	0.000348	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—IL6—Crohn's disease	7.64e-05	0.000347	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CRP—Crohn's disease	7.61e-05	0.000346	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—IL6—Crohn's disease	7.6e-05	0.000345	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.58e-05	0.000344	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IFNG—Crohn's disease	7.51e-05	0.000341	CbGpPWpGaD
Sirolimus—MTOR—Disease—RBX1—Crohn's disease	7.46e-05	0.000339	CbGpPWpGaD
Sirolimus—MTOR—Disease—HSPA1B—Crohn's disease	7.46e-05	0.000339	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RASGRP1—Crohn's disease	7.45e-05	0.000339	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—STAT3—Crohn's disease	7.44e-05	0.000338	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2RA—Crohn's disease	7.36e-05	0.000334	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GPX4—Crohn's disease	7.35e-05	0.000334	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—JAK2—Crohn's disease	7.3e-05	0.000332	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR4—Crohn's disease	7.29e-05	0.000331	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—Crohn's disease	7.27e-05	0.00033	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD4—Crohn's disease	7.25e-05	0.00033	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—FADS1—Crohn's disease	7.2e-05	0.000327	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—Crohn's disease	7.15e-05	0.000325	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—Crohn's disease	7.15e-05	0.000325	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	7.15e-05	0.000325	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL18—Crohn's disease	7.13e-05	0.000324	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GCKR—Crohn's disease	7.09e-05	0.000322	CbGpPWpGaD
Sirolimus—MTOR—Immune System—UBE2D1—Crohn's disease	7.09e-05	0.000322	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—Crohn's disease	7.09e-05	0.000322	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RBX1—Crohn's disease	7.04e-05	0.00032	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—Crohn's disease	7.02e-05	0.000319	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—Crohn's disease	6.99e-05	0.000318	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—STAT3—Crohn's disease	6.97e-05	0.000317	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD4—Crohn's disease	6.92e-05	0.000315	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RIPK2—Crohn's disease	6.87e-05	0.000312	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ITGA4—Crohn's disease	6.87e-05	0.000312	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PTGER4—Crohn's disease	6.86e-05	0.000312	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SOCS1—Crohn's disease	6.75e-05	0.000307	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GPX4—Crohn's disease	6.74e-05	0.000306	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ICAM1—Crohn's disease	6.71e-05	0.000305	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL3—Crohn's disease	6.7e-05	0.000305	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.7e-05	0.000305	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1B—Crohn's disease	6.7e-05	0.000304	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MTMR3—Crohn's disease	6.68e-05	0.000303	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD4—Crohn's disease	6.65e-05	0.000302	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—Crohn's disease	6.56e-05	0.000298	CbGpPWpGaD
Sirolimus—MTOR—Disease—UBE2D1—Crohn's disease	6.55e-05	0.000297	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GCKR—Crohn's disease	6.51e-05	0.000296	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RASGRP1—Crohn's disease	6.48e-05	0.000295	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD79A—Crohn's disease	6.46e-05	0.000294	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TAB1—Crohn's disease	6.34e-05	0.000288	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	6.33e-05	0.000288	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2RA—Crohn's disease	6.33e-05	0.000288	CbGpPWpGaD
Sirolimus—FGF2—Disease—SMAD3—Crohn's disease	6.31e-05	0.000287	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NOD2—Crohn's disease	6.23e-05	0.000283	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—UBE2D1—Crohn's disease	6.18e-05	0.000281	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—STAT3—Crohn's disease	6.07e-05	0.000276	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RIPK2—Crohn's disease	5.99e-05	0.000272	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—Crohn's disease	5.97e-05	0.000271	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.93e-05	0.000269	CbGpPWpGaD
Sirolimus—MTOR—Immune System—SOCS1—Crohn's disease	5.87e-05	0.000267	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL3—Crohn's disease	5.84e-05	0.000265	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SMAD3—Crohn's disease	5.83e-05	0.000265	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR6—Crohn's disease	5.78e-05	0.000263	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR4—Crohn's disease	5.72e-05	0.00026	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TYK2—Crohn's disease	5.68e-05	0.000258	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RASGRP1—Crohn's disease	5.65e-05	0.000257	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—STAT3—Crohn's disease	5.62e-05	0.000255	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ICAM1—Crohn's disease	5.49e-05	0.000249	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TYK2—Crohn's disease	5.43e-05	0.000247	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—JAK2—Crohn's disease	5.42e-05	0.000246	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2RA—Crohn's disease	5.4e-05	0.000245	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.32e-05	0.000242	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL18—Crohn's disease	5.29e-05	0.00024	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—Crohn's disease	5.25e-05	0.000239	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RBX1—Crohn's disease	5.23e-05	0.000237	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—FADS1—Crohn's disease	5.2e-05	0.000236	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—Crohn's disease	5.19e-05	0.000236	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TYK2—Crohn's disease	5.19e-05	0.000236	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—JAK2—Crohn's disease	5.18e-05	0.000235	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—Crohn's disease	5.14e-05	0.000233	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SOCS1—Crohn's disease	5.12e-05	0.000233	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PTGER4—Crohn's disease	5.09e-05	0.000231	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.07e-05	0.00023	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MTMR3—Crohn's disease	5.04e-05	0.000229	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—JAK2—Crohn's disease	4.95e-05	0.000225	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—Crohn's disease	4.93e-05	0.000224	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—Crohn's disease	4.91e-05	0.000223	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—Crohn's disease	4.88e-05	0.000222	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GPX4—Crohn's disease	4.87e-05	0.000221	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—Crohn's disease	4.87e-05	0.000221	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.82e-05	0.000219	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GCKR—Crohn's disease	4.71e-05	0.000214	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2RA—Crohn's disease	4.7e-05	0.000213	CbGpPWpGaD
Sirolimus—MTOR—Disease—SMAD3—Crohn's disease	4.68e-05	0.000213	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—UBE2D1—Crohn's disease	4.58e-05	0.000208	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—Crohn's disease	4.52e-05	0.000205	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TYK2—Crohn's disease	4.46e-05	0.000203	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RIPK2—Crohn's disease	4.44e-05	0.000202	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.44e-05	0.000202	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—Crohn's disease	4.43e-05	0.000201	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMAD3—Crohn's disease	4.42e-05	0.000201	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL3—Crohn's disease	4.33e-05	0.000197	CbGpPWpGaD
Sirolimus—FGF2—Immune System—JAK2—Crohn's disease	4.25e-05	0.000193	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—Crohn's disease	4.25e-05	0.000193	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—Crohn's disease	4.24e-05	0.000193	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RASGRP1—Crohn's disease	4.19e-05	0.00019	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—Crohn's disease	4.18e-05	0.00019	CbGpPWpGaD
Sirolimus—FGF2—Disease—TYK2—Crohn's disease	4.12e-05	0.000187	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2RA—Crohn's disease	4.09e-05	0.000186	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—Crohn's disease	4.07e-05	0.000185	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—Crohn's disease	4.03e-05	0.000183	CbGpPWpGaD
Sirolimus—FGF2—Disease—JAK2—Crohn's disease	3.93e-05	0.000178	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—FADS1—Crohn's disease	3.93e-05	0.000178	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—Crohn's disease	3.92e-05	0.000178	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TYK2—Crohn's disease	3.8e-05	0.000173	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—STAT3—Crohn's disease	3.8e-05	0.000173	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SOCS1—Crohn's disease	3.8e-05	0.000173	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—Crohn's disease	3.74e-05	0.00017	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—Crohn's disease	3.72e-05	0.000169	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—Crohn's disease	3.72e-05	0.000169	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—Crohn's disease	3.7e-05	0.000168	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GPX4—Crohn's disease	3.68e-05	0.000167	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.65e-05	0.000166	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—STAT3—Crohn's disease	3.63e-05	0.000165	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—JAK2—Crohn's disease	3.63e-05	0.000165	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.59e-05	0.000163	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GCKR—Crohn's disease	3.55e-05	0.000161	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—Crohn's disease	3.31e-05	0.00015	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TYK2—Crohn's disease	3.31e-05	0.00015	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMAD3—Crohn's disease	3.28e-05	0.000149	CbGpPWpGaD
Sirolimus—MTOR—Immune System—JAK2—Crohn's disease	3.16e-05	0.000143	CbGpPWpGaD
Sirolimus—FGF2—Immune System—STAT3—Crohn's disease	3.12e-05	0.000142	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.11e-05	0.000141	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—Crohn's disease	3.1e-05	0.000141	CbGpPWpGaD
Sirolimus—MTOR—Disease—TYK2—Crohn's disease	3.06e-05	0.000139	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2RA—Crohn's disease	3.04e-05	0.000138	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—Crohn's disease	2.99e-05	0.000136	CbGpPWpGaD
Sirolimus—MTOR—Disease—JAK2—Crohn's disease	2.91e-05	0.000132	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TYK2—Crohn's disease	2.88e-05	0.000131	CbGpPWpGaD
Sirolimus—FGF2—Disease—STAT3—Crohn's disease	2.88e-05	0.000131	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—Crohn's disease	2.78e-05	0.000126	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—Crohn's disease	2.76e-05	0.000126	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—Crohn's disease	2.76e-05	0.000126	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—JAK2—Crohn's disease	2.75e-05	0.000125	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—Crohn's disease	2.74e-05	0.000125	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—STAT3—Crohn's disease	2.66e-05	0.000121	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—Crohn's disease	2.66e-05	0.000121	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—Crohn's disease	2.54e-05	0.000115	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—Crohn's disease	2.51e-05	0.000114	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—FADS1—Crohn's disease	2.42e-05	0.00011	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.41e-05	0.00011	CbGpPWpGaD
Sirolimus—MTOR—Immune System—STAT3—Crohn's disease	2.32e-05	0.000105	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GPX4—Crohn's disease	2.27e-05	0.000103	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—Crohn's disease	2.26e-05	0.000103	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GCKR—Crohn's disease	2.19e-05	9.94e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—Crohn's disease	2.18e-05	9.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TYK2—Crohn's disease	2.14e-05	9.72e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—STAT3—Crohn's disease	2.14e-05	9.72e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—Crohn's disease	2.07e-05	9.41e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—JAK2—Crohn's disease	2.04e-05	9.27e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—STAT3—Crohn's disease	2.02e-05	9.17e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—Crohn's disease	2.01e-05	9.15e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—Crohn's disease	1.98e-05	8.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—Crohn's disease	1.86e-05	8.46e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—Crohn's disease	1.86e-05	8.45e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.81e-05	8.24e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—Crohn's disease	1.62e-05	7.35e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—STAT3—Crohn's disease	1.5e-05	6.81e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—Crohn's disease	1.5e-05	6.81e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—Crohn's disease	1.49e-05	6.79e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—Crohn's disease	1.41e-05	6.41e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.31e-05	5.95e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—Crohn's disease	1.13e-05	5.14e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—Crohn's disease	1.05e-05	4.75e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—Crohn's disease	9.89e-06	4.49e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—Crohn's disease	6.96e-06	3.16e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—Crohn's disease	6.09e-06	2.77e-05	CbGpPWpGaD
